×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
合肥物质科学研究院 [7]
四川大学 [5]
复旦大学上海医学院 [4]
中国医学科学院 北京... [4]
湖南大学 [3]
西安交通大学 [2]
更多...
内容类型
期刊论文 [33]
发表日期
2022 [4]
2021 [5]
2019 [12]
2018 [7]
2017 [3]
2016 [1]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共33条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
发表日期升序
发表日期降序
提交时间升序
提交时间降序
题名升序
题名降序
作者升序
作者降序
The Efficacy of PD-1/PD-L1 Inhibitors in Patients with Liver Metastasis of Non-Small Cell Lung Cancer: A Real-World Study
期刊论文
CANCERS, 2022, 卷号: 14
作者:
Xie, Mingying
;
Li, Na
;
Xu, Xiaoling
;
Xu, Yanjun
;
Li, Hui
收藏
  |  
浏览/下载:23/0
  |  
提交时间:2022/12/22
liver metastasis
non-small cell lung cancer
PD-L1
PD-1
PD-L1 inhibitor
CD8+T cell
Sugemalimab vs Placebo after cCRT or sCRT in pts with Unresectable Stage III NSCLC: Final PFS Analysis of a Phase 3 Study
期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2022, 卷号: 17
作者:
Wu, Y. -L.
;
Zhou, Q.
;
Chen, M.
;
Pan, Y.
;
Jian, O.
收藏
  |  
浏览/下载:18/0
  |  
提交时间:2022/12/23
CCRT
sCRT
PD-L1 inhibitor
Case Report: Hepatic Sarcoid-Like Reaction Associated With Checkpoint Inhibition in a NSCLC Patient and a Literature Review
期刊论文
FRONTIERS IN ONCOLOGY, 2022, 卷号: 12
作者:
Lin, Yuxin
;
Zhu, Wei
;
Wu, Bingchen
;
Lan, Huiyin
收藏
  |  
浏览/下载:20/0
  |  
提交时间:2022/05/16
Sarcoid-like reaction
immune checkpoint inhibitor
Toripalimab
PD-1
case report
High efficacy of PD-1 inhibitor after initial failure of PD-L1 inhibitor in Relapsed/Refractory classical Hodgkin Lymphoma
期刊论文
BMC CANCER, 2022, 卷号: 22
作者:
Chen, Xi
;
Kong, Haiying
;
Luo, Linxiang
;
Han, Shuiyun
;
Lei, Tao
收藏
  |  
浏览/下载:43/0
  |  
提交时间:2022/02/14
Hodgkin lymphoma
PD-1 inhibitor
PD-L1 inhibitor
PD-L2
Molecular phenotype
Tumor microenvironment
The prognostic impact of mild and severe immune-related adverse events in non-small cell lung cancer treated with immune checkpoint inhibitors: a multicenter retrospective study
期刊论文
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021
作者:
Wang, Wenxian
;
Gu, Xiaodong
;
Wang, Liping
;
Pu, Xingxiang
;
Feng, Huijing
收藏
  |  
浏览/下载:27/0
  |  
提交时间:2022/01/10
Non-small cell lung cancer
PD-L1
Immune checkpoint inhibitor
Immune-related adverse event
Acid-activatible micelleplex delivering siRNA-PD-L1 for improved cancer immunotherapy of CDK4/6 inhibition
期刊论文
CHINESE CHEMICAL LETTERS, 2021, 卷号: 32, 期号: 6, 页码: 1929-1936
作者:
Gao, Jing
;
Zhang, Hanwu
;
Zhou, Fengqi
;
Hou, Bo
;
Chen, Meiwan
收藏
  |  
浏览/下载:17/0
  |  
提交时间:2021/08/17
Cancer immunotherapy
siRNA delivery
Acid-activatible micelleplex
CDK4
6 inhibitor
PD-L1 knockdown
Discovery of a new inhibitor targeting PD-L1 for cancer immunotherapy
期刊论文
NEOPLASIA, 2021, 卷号: 23, 期号: 3, 页码: 281-293
作者:
Wang, Fengling
;
Ye, Wenling
;
Wang, Shuang
;
He, Yongxing
;
Zhong, Haiyang
收藏
  |  
浏览/下载:32/0
  |  
提交时间:2021/12/10
PD-1
PD-L1
Inhibitor
APBC
Cancer immunotherapy
Original Anti-PD1 checkpoint inhibitor with or without chemotherapy for patients with recurrent and metastatic nasopharyngeal carcinoma
期刊论文
TRANSLATIONAL ONCOLOGY, 2021, 卷号: 14
作者:
Jin, Ting
;
Zhang, Qun
;
Jin, Qi-Feng
;
Hua, Yong-Hong
;
Chen, Xiao-Zhong
收藏
  |  
浏览/下载:16/0
  |  
提交时间:2022/01/25
Nasopharyngeal carcinoma
Metastasis
Chemotherapy
Recurrence
Anti-PD1 checkpoint inhibitor
Remarkable Response of Toripalimab Combined with Chemotherapy in Sarcomatoid Carcinoma of Palatine Tonsil: A Case Report
期刊论文
JOURNAL OF MULTIDISCIPLINARY HEALTHCARE, 2021, 卷号: 14
作者:
Huang, Jiahuan
;
Lei, Lei
;
Chen, Bo
;
Pan, Guoqiang
;
Wang, Xiaojiao
收藏
  |  
浏览/下载:33/0
  |  
提交时间:2021/04/26
chemotherapy
combination therapy
palatine tonsil cancer
PD-1 inhibitor
sarcomatoid carcinoma
Prim-O-glucosylcimifugin enhances the antitumour effect of PD-1 inhibition by targeting myeloid-derived suppressor cells
期刊论文
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 卷号: 7, 期号: 1, 页码: 15
作者:
Gao, Wanfeng
;
Zhang, Xiaoyun
;
Yang, Wendong
;
Dou, Daolei
;
Zhang, Heng
收藏
  |  
浏览/下载:72/0
  |  
提交时间:2020/01/10
Prim-O-glucosylcimifugin
Myeloid-derived suppressor cells
Proliferation
Metabolism
PD-1 inhibitor
©版权所有 ©2017 CSpace - Powered by
CSpace